02-Nov-2026 19:01:12
VALIANTLABGeneral news
VALIANT LABORATORIES Q2 FY27 ; NET PROFIT DOWN 98% AT ₹0.43 CR (QOQ), UP 107% (YOY)
REVENUE UP 1% AT ₹117 CR (QOQ), UP 153% (YOY) EBITDA DOWN 82% AT ₹5 CR (QOQ), UP 6477% (YOY) MARGINS AT 4.4% VS 25.4% (QOQ), 0.2% (YOY)
Valiant Laboratories Limited